BP587

Fluticasonpropionat

British Pharmacopoeia (BP) Reference Standard

• Synonym(e): (6α,11β,16α,17α)-6,9-Difluor-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-dien-17-thiocarbonsäure-S-(fluormethyl)-ester
• Empirische Formel (Hill-System): C₂₅H₃₁F₃O₅S
• CAS-Nummer: 80474-14-2
• Molekulargewicht: 500.57
• MDL-Nummer: MFCD00866007
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: fluticasone
• Form: solid
• Haltbarkeit: limited shelf life, expiry date on the label
• Hersteller/Markenname: BP
• Anwendung(en): pharmaceutical; pharmaceutical small molecule
• Format: neat
• Lagertemp.: 2-8°C
• SMILES String: CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF
• InChI: 1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1
• InChIKey: WMWTYOKRWGGJOA-CENSZEJFSA-N
• Angaben zum Gen: human ... NR3C1(2908)

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Fluticasone propionate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Fluticasone and Salmeterol Inhalation Powder

Fluticasone and Salmeterol Inhalation Powder, pre-metered

Fluticasone Nasal Spray

Fluticasone and Salmeterol Pressurised Inhalation, Suspension

Fluticasone Pressurised Inhalation

Fluticasone Nasal Drops

Fluticasone Cream

Fluticasone Inhalation Powder

Fluticasone Ointment

Fluticasone Inhalation Powder, pre-metered

Biochem./physiol. Wirkung

Fluticasonpropionat ist ein Glucocorticoid der zweiten Generation. Es wird als entzündungshemmendes Mittel bei Asthma verwendet. Eine erhöhte konzentrationsabhängige eosinophile Apoptose über den Glucocorticoid-Rezeptor wurde gezeigt.

Verpackung

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08
• Signalwort: Warning
• H-Sätze: H361f,H373
• P-Sätze: P202 - P260 - P280 - P308 + P313 - P405 - P501
• Gefahreneinstufungen: Repr. 2 - STOT RE 2
• Zielorgane: Endocrine system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable